IP Library Granted Patent US 11,801,382
Granted Patent B1
US 11,801,382 · App. 17/355,507 · Granted Oct 31, 2023

Motor function in spinal cord injury patients via electrical stimulation, and associated systems and methods

Inventor: Alex Zinner (Redwood City, CA)
Assignee: Nevro Corp.
A61N1/36003A61N1/0553A61N1/36062A61N1/36157A61N1/36175
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,801,382
App. No.
17/355,507
Granted
Oct 31, 2023
Kind
B1
Abstract

Improving motor function in spinal cord injury patients (among others) via electrical stimulation, and associated systems and methods are disclosed. A representative method includes, in a patient having a spinal cord injury, improving the patient's gait response by delivering an electrical signal that includes repeating pulse packets delivered at a first frequency of from 2 Hz to 200 Hz. The electrical signal is delivered from an epidural location at the patient's spinal cord, and the individual pulse packets include a first period during which pulses are delivered at a first frequency of from 1 kHz to 5 kHz and a first pulse width of from 80 microseconds to 400 microseconds and a first amplitude from 0.1 mA to 20 mA, followed by a second period during which pulses are (a) not delivered, or (b) delivered at a second frequency higher than the first frequency, and/or a second pulse width shorter than the first pulse width, and/or a second amplitude less than the first amplitude.

Claims (44)

1. A patient treatment system for improving a patient's gait, comprising:

a signal generator; and

a non-transitory medium having instructions that, when executed, direct the signal generator to generate an electrical signal that includes repeating pulse packets delivered to an implantable signal delivery device at a packet frequency of from 2 Hz to 200 Hz, and wherein individual pulse packets include:

a first period during which bi-phasic pulses are delivered at a first frequency of from 1 kHz to 5 kHz, a first pulse width of from 80 microseconds to 400 microseconds, and a first amplitude from 0.1 mA to 20 mA; followed by

a second period during which bi-phasic pulses are (a) not delivered, or (b) delivered at a second frequency higher than the first frequency, and/or a second pulse width that is shorter than the first pulse width, and/or a second amplitude less than the first amplitude,

wherein the instructions, when executed, are configured to improve a patient'gait, via the electrical signal.

2. The system of claim 1 , further comprising the implantable signal delivery device.

3. The system of claim 2 wherein the implantable signal delivery device is implantable at an epidural location of a patient's spinal cord.

4. The system of claim 2 wherein the signal delivery device is implanted, and wherein an electrical contact carried by the signal delivery device is positioned at an epidural location of a patient at a vertebral level of T8-T12.

5. The system of claim 2 wherein the signal delivery device is implanted, and wherein an electrical contact carried by the signal delivery device is positioned to deliver the electrical signal to a dorsal region of the patient's spinal cord.

6. The system of claim 2 wherein the signal delivery device includes an elongated lead.

7. The system of claim 2 wherein the signal delivery device includes a paddle.

8. The system of claim 1 wherein the signal generator is implantable.

9. The system of claim 1 wherein a portion of the machine-readable medium is implantable and another portion is not implantable.

10. The system of claim 1 wherein the machine-readable medium is carried by the signal generator.

11. The system of claim 1 wherein the bi-phasic pulses delivered during the first period have an amplitude of 5 mA.

12. The system of claim 1 wherein the bi-phasic pulses delivered during the second period have an amplitude of from 0.01 mA to 20 mA.

13. The system of claim 1 wherein the bi-phasic pulses delivered during the first period are square and symmetric.

14. The system of claim 1 wherein the bi-phasic pulses delivered during the second period are square and symmetric.

15. The system of claim 1 wherein the instructions, when executed, cause the electrical signal to be directed to the signal delivery device while the patient is undergoing ambulatory motion.

16. The system of claim 1 wherein the instructions, when executed, cause the electrical signal to aid a patient's proprioception.

17. The system of claim 1 wherein, during the second period, the pulses are not delivered.

18. The system of claim 1 wherein, during the second period, the pulses are delivered at the second frequency higher than the first frequency.

19. The system of claim 1 wherein, during the second period, the pulses are delivered at the second amplitude less than the first amplitude.

20. The system of claim 1 wherein:

the packet frequency is 33 Hz;

the first frequency is 3 kHz, the first pulse width is 140 microseconds, and the first period is 3 milliseconds; and

the second frequency is 10 kHz, the second pulse width is 30 microseconds, and the second period is 27 milliseconds.

21. A patient treatment system for improving a patient's gait, comprising:

a signal generator;

an epidurally-implantable signal delivery device coupleable to the signal generator; and

a non-transitory machine-readable medium having instructions that, when executed, direct the signal generator to generate an electrical signal that includes repeating pulse packets delivered at a packet frequency of from 2 Hz to 200 Hz and wherein individual pulse packets include:

a first period during which pulses are delivered at a first frequency of from 1 kHz to 5 kHz and a first pulse width of from 80 microseconds to 400 microseconds and a first amplitude from 0.1 mA to 20 mA; followed by

a second period during which pulses are delivered at a second frequency higher than the first frequency, and/or a second pulse width that is shorter than the first pulse width, and/or a second amplitude less than the first amplitude,

wherein the instructions, when executed, are configured to improve a patient's gait, via the electrical signal.

22. The system of claim 21 wherein the signal delivery device is implanted, and wherein an electrical contact carried by the signal delivery device is positioned at an epidural location of a patient at a vertebral level of T8-T12.

23. The system of claim 21 wherein the signal delivery device is implanted, and wherein an electrical contact carried by the signal delivery device is positioned to deliver the electrical signal to a dorsal region of the patient's spinal cord.

24. The system of claim 21 wherein the signal generator is implantable.

25. The system of claim 21 wherein pulses delivered during the first period are the bi-phasic, square and symmetric.

26. The system of claim 21 wherein the instructions, when executed, cause the electrical signal to be directed to the signal delivery device while the patient is undergoing ambulatory motion.

27. The system of claim 21 wherein the instructions, when executed, cause the electrical signal to aid a patient's proprioception.

28. The system of claim 21 wherein, during the second period, the pulses are not delivered.

29. The system of claim 21 wherein, during the second period, the pulses are delivered at the second frequency higher than the first frequency.

30. The system of claim 21 wherein, during the second period, the pulses are delivered at the second amplitude less than the first amplitude.

Assignments (3)
RELEASE OF SECURITY INTEREST Recorded Apr 4, 2025
From: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS AGENT
To: NEVRO CORP.
Reel/Frame 070743/0001 →
PATENT SECURITY AGREEMENT Recorded Dec 1, 2023
From: NEVRO CORP.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS AGENT
Reel/Frame 065744/0302 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 13, 2021
From: ZINNER, ALEX
To: NEVRO CORP.
Reel/Frame 057786/0080 →
Continuity (2)
Continuation 16575797 · Sep 19, 2019
Provisional Application 62733554 · Sep 19, 2018
Cited By (1)
US 12,465,776